2016: Why we started Rhino Repro
A note on origin — why a small group of South African veterinarians and reproductive biologists decided, in 2016, to build a biobank.

Rhino Repro began in 2016, around a kitchen table, with a question we couldn't talk ourselves out of.
The question was simple: if a particular black rhino bull dies tomorrow, what of him survives? In 2016, in most cases, the answer was nothing. His genes — specific, irreplaceable, the result of millennia of local adaptation — would be gone. Not "endangered". Gone.
What was already happening
By 2016 a generation of conservation work had already taken hold in South Africa. Reserves were being expanded. Anti-poaching units were better equipped. Translocation programmes were moving animals between fragmented populations to keep them genetically connected. All of it good, all of it necessary.
But none of it addressed what happens after a population goes through a bottleneck — a disease outbreak, a poaching surge, a localised extinction. After a bottleneck, the genetic diversity that was there before is gone, and no amount of careful breeding can put it back. You can save the individuals; you cannot recover the variation that was lost on the way down.
What was missing
What was missing was a parallel layer of insurance: a programme dedicated to capturing, validating, and storing the reproductive material of as many genetically-distinct rhinos as possible, while they were still alive. Not as a replacement for the field work, but as the underwriter of it.
The technology to do this had existed for decades in cattle. It had been adapted, partially, for a handful of zoo programmes. It had not been done at scale on free-ranging African rhino. The veterinary protocols did not exist. The cryostorage chain did not exist. The trust between reserves and a non-profit lab did not exist.
Why a non-profit
A commercial lab cannot do this work. Sample collection requires an animal sedation, which requires veterinary justification, which requires a non-commercial relationship with the reserve. Storage is decades-long, with no return on investment in any reasonable business sense. Sharing samples — across organisations, across borders, across decades — depends on the absence of profit motive.
Rhino Repro was incorporated as a non-profit in 2016 because the work, by its nature, has no other shape it can take. The samples we hold are not assets. They are deposits, held in trust, against a future that needs them.
What we owe the kitchen table
Almost a decade in, the protocols exist. The cryostorage chain exists. The trust exists. A working biobank exists, with the genetic material of dozens of individual rhinos, ready for whatever the next century turns out to require.
The original question is the same. We are still asking it, of every individual we encounter: if this animal dies tomorrow, what of it survives?
The answer, today, is no longer "nothing".